Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how cognitive rehabilitation is an effective, low-risk and low-cost approach to treating cognitive problems of multiple sclerosis, study found; and reads the column by Ed Tobias, MS Wire, “I’m Back on the MS ‘Bladder Coaster’.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how the first patient who completed GeNeuro’s ProTEct-MS Phase 2 trial has entered the study's extension, which will test higher doses of temelimab.Also, Price reads the column by Jamie Hughes, A Life in Letters, “You Don’t Always Need to Fix It”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mesenchymal stem cells can improve functional abilities and promote the remyelination in rodent models of MS, according to a meta-analysis.Plus, reads a column by John Connor, Fall Down, Get Up Again, “Groundhog Day, Groundhog Day, Groundhog Day, Groundhog Day.”Are you interested in learning more about multiple sclerosis? If so, please visit https://multiplesclerosisnewstoday.com

=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how in an unexpected discovery, scientists found that increasing the activity of PDGFRA reduces the production of myelin in the nervous system; and reads the column by Ed Tobias, MS Wire, “My Lemtrada Treatment, 5 Years Later.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a light-sensing protein present in the brain during fetal development may help explain why MS is more common among people born in spring.Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Making the Most of Both Good Days and Bad”.Are you interested in learning more about multiple sclerosis? If so, please visit https://multiplesclerosisnewstoday.com

=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Tecfidera led to fewer relapses in relapsing-remitting multiple sclerosis patients than Aubagio or injectable immunomodulators.Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “It’s Just One of Those MS ‘Snow Days’.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how women with relapsing-remitting MS who stop fingolimod – sold as Gilenya – to conceive or in early pregnancy have a higher relapse risk.Also, Price reads “Once More, With Feeling: How Singing Can Benefit MS Patients”, a column by Jamie Hughes.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Jenn Powell speaks with identical twins with MS Tamara Kahn and Terry Hord.Meet identical twins Tamara Kahn and Terry Hord. Identical in every way, both were diagnosed with multiple sclerosis twenty plus years ago. These two amazingly close sisters created “TwinsCoast2Coast” to inspire, empower, support, and educate others about the challenges of MS while also showing the positives that have followed. From childhood and early signs of MS to college, marriage, children, and life, these two have navigated the highs and lows of MS together. Listen in as these sisters-turned-advocates share how their life’s mission is to help others find their own way.Check out their website at https://twinscoast2coast.com/ or follow them on Instagram @twinscoast2coastJoin the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/

Follow us on social media:
Instagram - www.instagram.com/msnewstoday/
Facebook - www.facebook.com/multiplesclerosisnewstoday
Twitter - www.twitter.com/msnewstoday

For more news on Multiple Sclerosis visit:
www.multiplesclerosisnewstoday.com/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study that indicates how people who develop colorectal cancer are more likely to die from it if they have multiple sclerosis.Also, Price reads “MS and Fertility: Conflicts of the Heart and Mind”, a column by Beth Ullah.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about how anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of relapses in people with RRMSAlso, Price reads “Thanks to a Wheelchair Mishap, I was ‘Busy Goin’ Nowhere’, a column by John Connor.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/